-
Mashup Score: 0Sodium–glucose cotransporter 2 inhibitor use in early-phase acute coronary syndrome with severe heart failure - 8 month(s) ago
AbstractAims. Sodium–glucose cotransporter 2 inhibitor (SGLT2i) improves clinical outcomes in patients with heart failure (HF), but has limited evidence of SGLT
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 41
Objectives. This study was performed to the efficacy, safety and clinical consequences of abrupt cessation of quinapril therapy in a placebo-controlle…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
Withdrawal of #GDMT in HF consistently ➡️adverse clinical course⚠️ #ACEi in HFrEF (#QuinaprilHeartStudy) https://t.co/9AsSNhBxAv #SGLT2i in HF (#EMPEROR) https://t.co/Z6FPyhABjs #MRA in HFmrEF/HFpEF (tested in #FINEARTS) #GDMT in HFimpEF DCM (#TREDHF) https://t.co/oKGUIWqjXB https://t.co/JJz252EpAL https://t.co/39HPhyZHjw
-
-
Mashup Score: 5
Aims The Dapagliflozin Evaluation to Improve the Lives of Patients with Preserved Ejection Fraction Heart Failure (DELIVER) trial demonstrated the SGLT2i dapagliflozin to be beneficial in patients w…
Source: onlinelibrary.wiley.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1SGLT2 Inhibitors, Rapid Titration, IV Iron Get a Boost in New European HF Guideline - 8 month(s) ago
Other recommendations also released for endocarditis, cardiomyopathies, ACS, and more
Source: www.medpagetoday.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 22Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction - American College of Cardiology - 8 month(s) ago
Anthony A. Bavry, M.D., M.P.H., FACC
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 472023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - 8 month(s) ago
Your access to the latest cardiovascular news, science, tools and resources.
Source: www.escardio.orgCategories: Cardiologists, Latest HeadlinesTweet-
🔥 #ESCCongress 2023 Focus Update Guidelines on #HeartFailure are out 🚀 Finally The wisest & EB decision: #SGLT2i Class I in #HFmrEF & #HFpEF together with #diuretics Enjoy the revolution in #HeartFailure 🍀 @gcfmd @JavedButler1 @DrMarthaGulati https://t.co/MSi44kzLrE https://t.co/4w2Joh0dOs
-
-
Mashup Score: 12Dapagliflozin in Patients with Heart Failure and Deterioration in Estimated Glomerular Filtration Rate to - 8 month(s) ago
STRUCTURED ABSTRACT Background SGLT-2 inhibitors are guideline-recommended in the management of heart failure(HF). While these therapies can be initiated even in patients with comorbid CKD, some pa…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 6
An abstract is unavailable. This article is available as a PDF only.
Source: journals.lww.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 9Implementation of SGLT2 Inhibitors for Heart Failure with Reduced Ejection Fraction: Where We Are Versus Where We Need To Be - 9 month(s) ago
Click on the article title to read more.
Source: onlinelibrary.wiley.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3
An abstract is unavailable. This article is available as a PDF only.
Source: journals.lww.comCategories: Cardiologists, Latest HeadlinesTweet
#SGLT2i use in early-phase #ACS with severe heart failure https://t.co/LWhjrUuUuh